Guris, D, Strebel, PM, Bardenheier, B, et al. Changing epidemiology oi pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis
Yih, WK, Lett, SM, des Vignes, FN, Garrison, KM, Sipe, PL, Marchant, CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis
Cattaneo, LA, Reed, GW, Haase, DH, Wills, MJ, Edwards, KM. The sero-epidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis
Senzilet, LD, Halperin, SA, Spika, JS, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis
Centers for Disease Control and Prevention. Pertussis: United States, 1997-2000. MMWR
Martinez, SM, Kemper, CA, Haiduven, D, Cody, SH, Deresinski, SC. Azithromycin prophylaxis during a hospitalwide outbreak of pertussislike illness. Infect Control Hosp Epidemiol
Gehanno, J-F, Pestel-Caron, M, Nouvellon, M, Caillard, J-F. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol
Shefer, A, Dales, L, Nelson, M, Werner, B, Baron, B, Jackson, R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis
Iambert, H. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep
Klein, JO. History of macrolide use in pediatrics. Pediatr Infect Dis J
Mahon, BE, Rosenman, MB, Kleiman, MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr
Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin: Knoxville, Tennessee, 1999. MMWR
Hoppe, JE, Bryskier, A. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). Antimicrob Agents Chemother
Aoyama, T, Sunakawa, K, Iwata, S, Takeuchi, Y, Fujii, R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J Pediatr
Bace, A, Zrnic, T, Begovac, J, Kuzmanovic, N, Culig, J. Short-term treatment of pertussis with azithromycin in infants and young children. Eur J Clin Microbiol Infect Dis
Langley, JM, Halperin, SA, Boucher, FD, Smith, B, the Pediatric Investigators Collaborative Network on Infections in Canada. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics
Pichichero, ME, Hoeger, WJ, Casey, JR. Azithromycin for the treatment of pertussis. Pediatr Infect Dis J
American Academy of Pediatrics. Antibacterial drugs for pediatric patients beyond the newborn period. In: Pickering, LK, ed. 2000 Red Booh: Report of the Committee on Infectious Diseases, ed. 25. Elk Grove Village, IL: American Academy of Pediatrics; 2000:657.
Weber, DJ, Rutala, WA. Vaccines for health care workers. In: Plotkin, SA, Orenstein, WA, eds. Vaccines, ed. 4. Philadelphia: W. B. Saunders; 2004:1511–1538.
Marchant, CD, Loughlin, AM, Lett, SM, et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis
Halperin, SA, Bortolussi, R, Wort, AJ. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol
Kwantes, W, Joynson, DH, Williams, WO.
Bordetella pertussis isolation in general practice: 1977-79 whooping cough epidemic in West Glamorgan. J Hyg (Lond)
Medical Research Council. The prevention of whooping-cough by vaccination: a Medical Research Council investigation. BMJ
Cherry, JD. Pertussis in the preantibiotic and prevaccine era, with an emphasis on adult pertussis. Clin Infect Dis
Edwards, KM, Decker, MD. Pertussis vaccine. In: Plotkin, SA, Orenstein, WA, eds. Vaccines, ed. 4. Philadelphia: W. B. Saunders; 2004:471–528.
Strebel, P, Guris, D, Wassilak, SG. Pertussis. In: Wallace, RB, Doebbeling, BN, Last, JM, eds. Maxcy-Rosenau-Last: Public Health & Preventive Medicine. Stamford, CT: Appleton & Lange; 1998.
Heininger, U, Cherry, JD, Stehr, K, et al. Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pediatrics
Fine, PEM, Clarkson, JA, Miller, E. The efficacy of pertussis vaccines under conditions of household exposure: further analysis on the 197890 PHLS/ERL study in 21 area health authorities in England. Int J Epidemiol
Vitek, C, Pascual, FB, Baughman, AL, Murphy, TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J
Centers for Disease Control and Prevention. Pertussis deaths: United States, 2000. MMWR
American Academy of Pediatrics. Pertussis. In: Pickering, LK, ed. 2003 Red Book: Report of the Committee on Infectious Diseases, ed. 26. Elk Grove Village, IL: American Academy of Pediatrics; 2003:472–486.
Hospital Infection Control Practices Advisory Committee. Guideline for Infection Control in Health Care Personnel. Atlanta, GA: Centers for Disease Control and Prevention; 1998:312–313. Available at www.cdc.gov/ncidod/hip/guide/InfectControl98.pdf.
Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia. MMWR
Anti-Infective Drugs Advisory Committee. FDA Briefing Package: Zithromax (Azithromycin) Oral Suspension Single-Dose and Three-Day Treatment of Acute Otitis Media. Rockville, MD: LI.S. Food and Drug Administration; 2001. Available at www.fda.gov/ohrms/dockets/ac/01/briefing/3802bl_02_FDA.pdf.
Remington, JS, Klein, JO. Clinical Pharmacology of Antibacterial Agents in Infectious Diseases of the Fetus and Newborn Infant, ed. 4. Philadelphia: W. B. Saunders; 1995:1287–1336.
Hopkins, SJ. Clinical toleration and safety of azithromycin in adults and children. Review of Contemporary Pharmacotherapy